Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAHNa Zhu, Zia Ur Rehman, Jennifer M. Martin et al.|Genome Medicine|2021Cited by 86
A multidisciplinary approach to severe bronchopulmonary dysplasia is associated with resolution of pulmonary hypertensionDelphine Yung, Laurie C. Eldredge, Emma Jackson et al.|Frontiers in Pediatrics|2023Cited by 17
Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease–Associated Pulmonary HypertensionCaroline M. Daly, Allen D. Everett, Megan Griffiths et al.|Journal of the American Heart Association|2021Cited by 11
The Fontan Udenafil Exercise Longitudinal Trial: Subgroup AnalysisDavid Goldberg, Chenwei Hu, Adam M. Lubert et al.|Pediatric Cardiology|2023Cited by 8
Abstract 14404: The Fontan Udenafil Exercise Longitudinal Trial Subgroup AnalysisDavid Goldberg, Stephen M. Paridon, Russell Gongwer et al.|Circulation|2020Cited by 0